Resumo

NOGUES, Martín A et al. Inmunoglobulina subcutánea: Tratamiento en polineuropatía desmielinizante inflamatoria crónica. Medicina (B. Aires) [online]. 2016, vol.76, n.1, pp.36-39. ISSN 0025-7680.

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an acquired disease that may affect nerve roots and peripheral nerves. Despite its low incidence, diagnosis is particularly important because there are different effective treatments. Human immunoglobulin is one of the mainstays of the treatment. Although there are few studies up to date, subcutaneous immunoglobulin (IgSC) has been proposed as an alternative to intravenous administration with similar efficacy. We present three cases with definite CIDP, classified according to the European Federation of Neurological Societies / Peripheral Nerve, Society (EFNS /PNS) criteria in which was used SCIgG as a treatment after success with the intravenous route. The Overall Neuropathy Limitations Scale (ONLS) was used to estimate the changes in the muscular strength before and after treatment.

Palavras-chave : Chronic inflammatory polyradiculoneuropathy; Disability; Subcutaneous immunoglobulin.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )